LeonaBio, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
LeonaBio, Inc. (LONA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $149.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $75.00K, a 11.94% increase year-over-year.
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $74.00K, a 13.85% increase year-over-year.
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $72.00K, a 14.29% increase year-over-year.
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $69.00K, a 11.29% increase year-over-year.
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $273.00K, a 13.28% increase from fiscal 2024.
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $241.00K, a 12.62% increase from fiscal 2023.
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $214.00K, a 5.42% increase from fiscal 2022.
- LeonaBio, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $203.00K, a 30.97% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $149.00K 10-Q · filed 2026-08-14 | $221.00K derived: sum of 3 quarters · filed 2026-08-14 | $290.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $74.00K 10-Q · filed 2026-05-07 | $146.00K derived: sum of 2 quarters · filed 2026-05-07 | $215.00K derived: sum of 3 quarters · filed 2026-05-07 | $282.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $141.00K derived: sum of 2 quarters · filed 2026-03-31 | $208.00K derived: sum of 3 quarters · filed 2026-08-14 | $273.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $136.00K derived: sum of 2 quarters · filed 2026-08-14 | $201.00K 10-Q · filed 2025-11-06 | $264.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $132.00K 10-Q · filed 2026-08-14 | $195.00K derived: sum of 3 quarters · filed 2026-08-14 | $257.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $65.00K 10-Q · filed 2026-05-07 | $128.00K derived: sum of 2 quarters · filed 2026-05-07 | $190.00K derived: sum of 3 quarters · filed 2026-05-07 | $249.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $125.00K derived: sum of 2 quarters · filed 2026-03-31 | $184.00K derived: sum of 3 quarters · filed 2026-03-31 | $241.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $121.00K derived: sum of 2 quarters · filed 2025-11-06 | $178.00K 10-Q · filed 2025-11-06 | $234.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $116.00K 10-Q · filed 2025-08-07 | $172.00K derived: sum of 3 quarters · filed 2025-08-07 | $226.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $57.00K 10-Q · filed 2025-05-09 | $113.00K derived: sum of 2 quarters · filed 2025-05-09 | $167.00K derived: sum of 3 quarters · filed 2025-05-09 | $220.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $110.00K derived: sum of 2 quarters · filed 2025-02-27 | $163.00K derived: sum of 3 quarters · filed 2025-02-27 | $214.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $107.00K derived: sum of 2 quarters · filed 2024-11-07 | $158.00K 10-Q · filed 2024-11-07 | $207.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $104.00K 10-Q · filed 2024-08-01 | $153.00K derived: sum of 3 quarters · filed 2024-08-01 | $215.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $51.00K 10-Q · filed 2024-05-15 | $100.00K derived: sum of 2 quarters · filed 2024-05-15 | $162.00K derived: sum of 3 quarters · filed 2024-05-15 | $209.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $111.00K derived: sum of 2 quarters · filed 2024-02-22 | $158.00K derived: sum of 3 quarters · filed 2024-02-22 | $203.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $109.00K derived: sum of 2 quarters · filed 2023-11-09 | $154.00K 10-Q · filed 2023-11-09 | $198.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $92.00K 10-Q · filed 2023-08-10 | $136.00K derived: sum of 3 quarters · filed 2023-08-10 | $179.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $45.00K 10-Q · filed 2023-05-11 | $89.00K derived: sum of 2 quarters · filed 2023-05-11 | $132.00K derived: sum of 3 quarters · filed 2023-05-11 | $172.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $87.00K derived: sum of 2 quarters · filed 2023-03-23 | $127.00K derived: sum of 3 quarters · filed 2023-03-23 | $155.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $83.00K derived: sum of 2 quarters · filed 2022-11-10 | $111.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $68.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $28.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |